Clinical Research Solutions
ProPharma Group announced that its wholly-owned subsidiary ProPharma Group The Netherlands B.V., has obtained an authorization for a manufacturing and import (MIA) license. Following successful...
Clinical Research Solutions
ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...
Clinical Research Solutions
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
Clinical Research Solutions
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
Clinical Research Solutions
Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company") from Linden Capital Partners. Financial terms of the...
Clinical Research Solutions
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced an agreement to sell ProPharma Group (the “Company”) to Odyssey...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Southwood Research. Based in Buckinghamshire, United Kingdom, Southwood Research is a leading provider of...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...